Want to see SG:P8A full AI Analyst Report?
P8A Stock Chart & Stats
S$0.13
S$0.00(0.00%)
At close: 4:00 PM EST
S$0.13
S$0.00(0.00%)
Day’s Range― - ―
52-Week RangeS$0.12 - S$0.27
Previous CloseN/A
Volume12.00K
Average Volume (3M)14.19K
Market Cap
S$37.53M
Enterprise ValueS$22.62M
Total Cash (Recent Filing)S$45.33M
Total Debt (Recent Filing)S$4.39M
Price to Earnings (P/E)―
Beta0.10
Next Earnings
Aug 07, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.05
Shares Outstanding267,525,360
10 Day Avg. Volume3,230
30 Day Avg. Volume14,193
Financial Highlights & Ratios
PEG Ratio0.08
Price to Book (P/B)0.32
Price to Sales (P/S)0.86
P/FCF Ratio-45.71
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Conservatively Levered Balance SheetA very low debt-to-equity ratio (~0.04) gives the company durable financial flexibility to absorb operational volatility, fund working capital or selective investments, and avoid near-term refinancing pressure. This buffer supports continuity of operations over the next 2–6 months while management addresses profitability.
High Gross Margin On Core ServicesA gross margin near 57% indicates the core processing and storage services have healthy unit economics and pricing power. If operating costs are controlled or scaled down, this structural margin supports a feasible path back to operating profitability and sustained cash generation over the medium term.
Recurring Fee Model And Hospital Channel PartnershipsA business model built on upfront enrolment fees and ongoing storage subscriptions creates recurring, predictable revenue and high customer lifetime value. Established hospital and clinician distribution relationships lower acquisition costs and sustain demand generation, strengthening revenue stability over coming quarters.
Bears Say
Deep Operating And Net LossesLarge negative EBIT and net margins mean the business is burning capital at the operating level; this is a structural profitability issue rather than a short blip. Persisting losses will erode equity, constrain reinvestment, and require sustained corrective action to restore durable returns to shareholders.
Negative Operating And Free Cash FlowNegative operating and free cash flow indicate the company is not self-funding its operations and investments. Over a multi-month horizon this raises execution risk, creating reliance on external financing or equity; such dependence can limit strategic flexibility and slow recovery initiatives.
Loss Of Prior Profitability TrendA clear structural deterioration from prior profitable years suggests persistent demand, pricing, or cost issues rather than a one-off shock. Reversing this trend requires sustained execution on revenue growth or cost restructuring; failure to do so would impair medium-term viability and investor confidence.
Cordlife Group News
P8A FAQ
What was Cordlife Group Limited’s price range in the past 12 months?
Cordlife Group Limited lowest share price was S$0.12 and its highest was S$0.27 in the past 12 months.
What is Cordlife Group Limited’s market cap?
Cordlife Group Limited’s market cap is S$37.53M.
When is Cordlife Group Limited’s upcoming earnings report date?
Cordlife Group Limited’s upcoming earnings report date is Aug 07, 2026 which is in 12 days.
How were Cordlife Group Limited’s earnings last quarter?
Cordlife Group Limited released its earnings results on May 13, 2026. The company reported -S$0.007 earnings per share for the quarter, missing the consensus estimate of N/A by -S$0.007.
Is Cordlife Group Limited overvalued?
According to Wall Street analysts Cordlife Group Limited’s price is currently Overvalued.
Does Cordlife Group Limited pay dividends?
Cordlife Group Limited pays a N/A dividend of S$0.009 which represents an annual dividend yield of N/A. See more information on Cordlife Group Limited dividends here
What is Cordlife Group Limited’s EPS estimate?
Cordlife Group Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Cordlife Group Limited have?
Cordlife Group Limited has 267,525,360 shares outstanding.
What happened to Cordlife Group Limited’s price movement after its last earnings report?
Cordlife Group Limited reported an EPS of -S$0.007 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Cordlife Group Limited?
Currently, no hedge funds are holding shares in SG:P8A
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Cordlife Group Limited
Established in Singapore in 2001, Cordlife Group Limited functions as an investment holding company, delivering cord blood banking solutions across a global footprint that includes Singapore, Hong Kong, India, Malaysia, and the Philippines. Its operations are structured into two distinct divisions: Banking and Diagnostics. The Banking division is responsible for the collection, processing, storage, and analysis of vital biological samples such as cord blood, cord lining, and various tissue samples. Meanwhile, the Diagnostics division furnishes an array of diagnostic tests, encompassing genetic and metabolic screenings for newborns, pediatric vision and hearing assessments, allergen testing for children, and genetic evaluations for talent identification. Beyond these core services, Cordlife also engages in corneal lenticule banking, gut microbiome storage, and offers lifestyle-focused genetic screening for adults. The company further provides "Moms Up," a mobile application designed to supply parenting information and resources pertinent to health, wellness, and lifestyle needs. Completing its diverse portfolio, Cordlife offers medical laboratory services, marketing support, property investment, alongside specialized consulting and research and development in the medical and pharmaceutical sectors.
Technical Analysis
Raffles Medical Group
―
Thomson Medical Group Ltd.
―
ISEC Healthcare Ltd
―
OUE Lippo Healthcare Limited
―
Bangkok Dusit Medical Services Public Co Ltd Shs UnSp Singapore Depositary Receipt Repr 2/1 Sh
―